© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Eton Pharmaceuticals, Inc. (ETON) shows an Average True Range (ATR) of 0.67 and an Enterprise Value of 66.06M. Its average trading volume over the past 3 months is 270.62K, indicating liquidity. These fundamental metrics provide insight into ETON's underlying financial health and market activity.
Eton Pharmaceuticals, Inc. (ETON) technical indicators as of January 1, 2026: the SMA 20 is 2.54%, SMA 50 at -0.83%, and SMA 200 at 2.23%. The RSI 14 value is 53.81, suggesting its current momentum. These technical analysis signals help assess ETON's price trends and potential future movements.
Eton Pharmaceuticals, Inc. (ETON) stock performance overview as of January 1, 2026: The 52-week high is $23 (currently -26.48% below), and the 52-week low is $11.09 (currently 52.53% above). Over the past year, ETON's performance is 33.57%, compared to the S&P 500's 12.29% change.
According to market data, Eton Pharmaceuticals, Inc. (ETON) stock's recent performance metrics show that over the last month, ETON is 4.71%, with a Year-to-Date (YTD) performance of 26.95%. Over the past year, the stock has seen a 33.57% change. These figures summarize ETON's price movements across various periods, reflecting its historical returns.
According to current financial data, ETON stock's P/E (TTM) ratio is -68.02, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ETON, including P/S (6.45), P/B (19.65), and P/FCF (21.57), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.